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Abstract
Recent advances in whole genome sequencing have brought the vision of personal genomics and
genomic medicine closer to reality. However, current methods lack clinical accuracy and the
ability to describe the context (haplotypes) in which genome variants co-occur in a cost-effective
manner. Here we describe a low-cost DNA sequencing and haplotyping process, Long Fragment
Read (LFR) technology, similar to sequencing long single DNA molecules without cloning or
separation of metaphase chromosomes. In this study, ten LFR libraries were made using only ~100
pg of human DNA per sample. Up to 97% of the heterozygous single nucleotide variants (SNVs)
were assembled into long haplotype contigs. Removal of false positive SNVs not phased by
multiple LFR haplotypes resulted in a final genome error rate of 1 in 10 Mb. Cost-effective and
accurate genome sequencing and haplotyping from 10-20 human cells, as demonstrated here, will
enable comprehensive genetic studies and diverse clinical applications.
The extraordinary advancements made in DNA sequencing technologies over the past few
years have led to the elucidation of ~10,0001-13 individual human genomes (30x or greater
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tbase coverage) from different ethnicities and using different technologies2-13 and at a
fraction of the cost10 of sequencing the original human reference genome14,15. While this is
a monumental achievement, the vast majority of these genomes have excluded a very
important element of human genetics. Individual human genomes are diploid in nature, with
half of the homologous chromosomes being derived from each parent. The context in which
variations occur on each individual chromosome can have profound effects on the
expression and regulation of genes and other transcribed regions of the genome16. Further,
determining if two potentially detrimental mutations occur within one or both alleles of a
gene is of paramount clinical importance.
Almost all recent human genome sequencing has been performed on short read-length (<200
bp), highly parallelized systems starting with hundreds of nanograms of DNA. These
technologies are excellent at generating large volumes of data quickly and economically.
Unfortunately short reads, often paired with small mate-gap sizes (500b-10kb), eliminate
most SNP phase information beyond a few kilobases8. Population based genotype data has
been used successfully to assemble short read data into long haplotype blocks3, however
these methods suffer from higher error rates and have difficulty phasing rare variants17.
Using pedigree information18 or combining it with population data provides additional
phasing power, however no combination of these methods are able to resolve de-novo
mutations17.
Currently four personal genomes, J. Craig Venter19, a Gujarati Indian (HapMap sample
NA20847)11, and two Europeans (Max Planck One (MP1)13 and HapMap Sample
NA1287820) which have been sequenced and assembled as diploid. All have involved
cloning long DNA fragments in a process similar to that used for the construction of the
human reference genome14,15. While these processes generate long phased contigs (N50s of
350 kb19, 386 kb11, 1 Mb13, and full-chromosome haplotypes in combination with parental
genotypes20) they require a large amount of initial DNA, extensive library processing, and
are currently too expensive11 to use in a routine clinical environment. Additionally, several
reports have recently demonstrated whole chromosome haplotyping through direct isolation
of metaphase chromosomes21-24. These methods have yet to be used for whole genome
sequencing and require preparation and isolation of whole metaphase chromosomes, which
can be challenging for some clinical samples. In this paper, we introduce Long Fragment
Read (LFR) technology, a process that enables genome sequencing and haplotyping at a
clinically relevant cost, quality and scale.
Long Fragment Read technology
The LFR approach can generate long-range phased SNPs because it is conceptually similar
to single molecule sequencing of fragments 10-1000 kb25 in length. This is achieved by the
stochastic separation of corresponding long parental DNA fragments into physically distinct
pools followed by subsequent fragmentation to generate shorter sequencing templates (Fig.
1a). The same principles are used in aliquoting fosmid clones11,13. As the fraction of the
genome in each pool decreases to less than a haploid genome, the statistical likelihood of
having a corresponding fragment from both parental chromosomes in the same pool
dramatically diminishes25. For example, 0.1 genome equivalents (300 Mb) per well yields
an approximately 10% chance that two fragments will overlap and a 50% chance those
fragments will be derived from separate parental chromosomes. The end result is an
approximately 5% overall chance that a particular well will be uninformative for a given
fragment. Likewise, the more individual pools interrogated the greater number of times a
fragment from the maternal and paternal homologs will be analysed in separate pools. The
current version of LFR uses a 384-well plate with 10-20% of a haploid genome in each well,
yielding a theoretical 19-38x physical coverage of both the maternal and paternal alleles of
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teach fragment (see Supplementary Materials and Supplementary Table 1 for an explanation
of how this amount of material was selected). This high initial DNA redundancy of 19-38x
versus recently described strategies using fosmid pools of 3x11 or 6x13 ensures complete
genome coverage and higher variant calling and phasing accuracy.
To prepare LFR libraries in a high-throughput manner we developed an automated process
that performs all LFR-specific steps in the same 384-well plate. First, a highly uniform
amplification using a modified, phi29 polymerase-based, multiple displacement
amplification (MDA)26 is performed to replicate each fragment about 10,000 times. Next,
through a process of five enzymatic steps within each well, without intervening purification
steps, DNA is fragmented and ligated with barcode adapters. Briefly, long DNA molecules
are processed to blunt ended 300-1,500 bp fragments through the novel process of
Controlled Random Enzymatic fragmenting (CoRE) (Supplementary Methods and
Supplementary Figures 2 and 3). Unique 10-base Reed-Solomon27 error correcting barcode
adapters (Supplementary Figure 4) are then ligated to fragmented DNA in each well using a
high yield, low chimera formation protocol10. Lastly, all 384 wells are combined and an
unsaturated polymerase chain reaction using primers common to the ligated adapters is
employed to generate sufficient template for massively parallel short read sequencing
platforms (see Supplementary Methods). The addition of the LFR pre-processing steps to the
standard library process currently adds about $100 to the reagent cost of our genome
sequencing (Supplementary Table 2).
LFR libraries from 100pg of isolated DNA or directly from 10 cells
As a demonstration of the power of LFR to determine an accurate diploid genome sequence
we generated three libraries of Yoruban female HapMap sample NA19240, six libraries
from European HapMap pedigree 1463 (Supplementary Figure 5), and a single library from
Personal Genome Project (PGP) sample NA20431. Pedigree 1463 and NA19240 have been
extensively studied in the HapMap Project28,29, the 1,000 Genomes Project30, and our own
efforts31. As a result, highly accurate haplotype information can be generated for these
samples based on the redundant sequence data from familial samples. One NA19240 LFR
library was made from 10 cells of the corresponding immortalized B-cell line, all other
libraries were made from an estimated 100-130 pg (equivalent to 15-20 cells) of denatured
high molecular weight genomic DNA (Supplementary Figure 6 and Supplementary
Methods). Libraries were analysed using Complete Genomics’ sequencing platform10. 35-
base mate-paired reads were mapped to the reference genome using a custom alignment
algorithm10,32 yielding on average more than 250 Gbs of mapped data with an average
genomic coverage >80x (Table 1 and Supplementary Table 3). Analysis of the mapped LFR
data shows two distinct characteristics attributable to MDA: slight underrepresentation of
GC rich sequences (Supplementary Figure 7) and an increase in chimeric sequences
(Supplementary Table 3). Additionally, coverage normalized across 100 kb windows was
more variable (Supplementary Figure 8). Nevertheless, almost all genomic regions were
covered with sufficient reads (5 or more) demonstrating that 10,000 fold MDA amplification
by our optimized protocol can be used for comprehensive genome sequencing. Barcodes
were used to group mapped reads based on their physical well location within each library
resulting in sparse regions of coverage interspersed between long spans with almost no read
coverage (Supplementary Figure 9). Each of these discrete regions of coverage represents a
physical DNA fragment. On average, each well contained 10-20% of a haploid genome
(300-600 Mb) in fragments ranging from 10 kb to over 300 kb in length with N50s of ~60
kb (Table 1). Initial fragment coverage was very uniform between chromosomes
(Supplementary Figure 10). As estimated from all detected fragments, the total amounts of
DNA used to make the two NA19240 libraries from extracted DNA were ~62 pg and 84 pg
(equivalent to 9.4 and 12.7 cells). This is less than the expected 100-130 pg indicating some
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tlost or undetected DNA or imprecision in DNA quantification. Interestingly, the 10-cell
library appeared to be made from ~90 pg (13.6 cells) of DNA, most likely due to some of
the cells being in S phase during isolation (Table 1).
LFR haplotyping results
To ensure complete representation of the genome we maximized the input of DNA
fragments for a given read coverage and number of aliquots (Supplementary Materials and
Supplementary Table 1). Unlike other experimental approaches11,13,20, this resulted in low-
coverage read data (<2x) for each fragment in each of the ~40 wells a fragment is found in.
This type of data is not useful for defining haplotypes for each initial fragment and required
the development of a novel phasing algorithm that statistically combines reads from related
fragments found in separate aliquots (Supplementary Methods and Fig. 2). Application of
our algorithm to the LFR libraries resulted in the placement of on average 92% of the
phasable heterozygous SNPs into long contigs with N50s of ~1 Mb and ~ 500 kb for
NA19240 and European samples, respectively (Table1 and Supplementary Table 4). The
large reduction in the N50 contig size for European samples can be explained by many more
regions of low heterozygosity (RLHs, Supplementary Tables 5-7, Supplementary Figure 11,
and Supplementary Materials) found in these genomes. Doubling the number of reads to
~160x coverage or combining replicate samples (a total of 768 independent wells), each
with ~80x coverage, pushed the phasing rate to ~96% (Table 1). Using only the SNP loci
called in the LFR library for phasing resulted mostly in a reduction in the total number of
phased SNPs by 5-15% (Table 1 and Supplementary Materials). Importantly, the 1.72
million heterozygous SNPs called and phased by the NA12892 LFR library alone was
slightly higher than the number of SNPs phased for a comparable sample using a fosmid
approach13,20 (Table 1). For NA19240, the 10-cell library phased over 98% of variants
phased by the two libraries made from isolated DNA demonstrating that LFR can be
successful starting from a small number of cells.
LFR reproducibility and phasing error rate analysis
To test LFR reproducibility we compared haplotype data between the two NA19240
replicate libraries. In general, the libraries were very concordant, with only 64 differences
per library in ~2.2 million heterozygous SNPs phased by both libraries (Supplementary
Table 8) or 1 of this error type in 44 Mb. LFR was also highly accurate when compared to
the conservative but accurate whole chromosome phasing generated from the parental
genomes NA19238 and NA19239 previously sequenced by multiple methods28-31
(Supplementary Table 4). Only ~60 instances in 1.57 million comparable individual loci
were found in which LFR phased a variant inconsistent with that of the parental haplotyping
(false phasing rate of 0.002% if half of discordances are due to sequencing errors in parental
genomes). The LFR data also contained ~135 contigs per library (2.2%) with one or more
flipped haplotype blocks (Supplementary Table 8). Extending these analyses to the
European replicate libraries of sample NA12877 (Supplementary Table 8) and comparing
them with a recent high quality family-based analysis18 yielded similar results assuming
each method contributes half of the observed discordance (Supplementary Table 9). In both
NA19240 and NA12877 libraries several contigs had dozens of flipped segments. The
majority of these contigs were located in regions of low heterozygosity, low read coverage
regions, or repetitive regions observed in an unexpectedly large number of wells (e.g.,
subtelomeric or centromeric regions). Most of these errors can be corrected by forcing the
LFR phasing algorithms to end contigs in these regions. Alternatively, these errors can be
removed with the simple, low cost addition of standard high density array genotype data (~1
million or greater SNPs) from at least one parent to the LFR assembly. We found that
parental genotypes can connect 98% of LFR phased heterozygous SNPs in full chromosome
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thaplotypes. Additionally, this data allows haplotypes to be assigned to maternal and paternal
lineages; information that is critical for incorporating parental imprinting in genetic
diagnoses in any experimental haplotyping approach. If parental data is unavailable
population genotype data could also be used to connect many of these LFR contigs, although
at the cost of increased phasing errors17.
Phasing de-novo mutations
As a demonstration of the completeness and accuracy of our diploid genome sequencing we
assessed phasing of 35 de-novo mutations recently reported in the genome of NA1924033.
34 of these mutations were called in either the standard genome or one of the LFR libraries.
Of those, 32 de-novo mutations were phased (16 coming from each parent) in at least one of
the two replicate LFR libraries (Supplementary Table 10). Not surprisingly, the two non-
phased variants reside in RLHs. Of these 32 variants, 21 were phased by Conrad et al.33 and
18 were consistent with LFR phasing results (Matthew Hurles personal communication).
The three discordances are likely due to errors in the previous study (Matthew Hurles
personal communication) confirming LFR accuracy, but not affecting the substantive
conclusions of the report.
Error reduction enabled by LFR for accurate genome sequencing from 10
cells
Substantial error rates (~1 SNV in 100-1,000 called kilobases) are a common attribute of all
current massively parallelized sequencing technologies2-10,18. These rates are most likely
too high for diagnostic use and complicate many studies searching for novel mutations. The
vast majority of errors are no more likely to occur on the maternal or paternal chromosome.
This lack of consistent phasing or presence in only a few aliquots can be exploited by LFR
to eliminate these errors from the final assembled haplotypes. To demonstrate this we
defined a set of heterozygous SNPs in NA19240 and NA12877 LFR libraries that were
reported with high confidence in each of the individual’s parents as matching the human
reference genome at both alleles (>85% of all heterozygous SNPs). There were about 44,000
of these heterozygous SNPs in NA19240 and 30,000 in NA12877 that met this criterion. By
virtue of their nonexistence in the parental genomes these variations are de novo mutations,
cell line specific somatic mutations, or false positive variants. Approximately 1,000-1,500 of
these variants were reproducibly phased in each of the two replicate LFR libraries from
samples NA19240 and NA12877 (Supplementary Table 11). These numbers are similar to
those previously reported for de-novo and cell line specific mutations in NA1924033. The
remaining variants are likely to be initial false positives of which only about 500 are phased
per library. This represents a 60 fold reduction of the false positive rate in those variations
that are phased. Only ~2,400 of these false variants are present in the standard libraries, of
which only ~260 are phased (<1 false positive SNV in 20 Mb; 5700 haploid Mb / 260
errors). Each LFR library exhibits a 15 fold increase, compared to a genome sequenced by
the standard process, in library specific false positive calls before phasing. The majority of
these false positive SNVs are likely to have been introduced by MDA; sampling of rare cell-
line variants may be responsible for a smaller percentage. Despite making LFR libraries
from 100 pg of DNA and introducing a large number of errors through MDA amplification,
applying the LFR phasing algorithm described above reduces the overall sequencing error
rate to 99.99999% (~600 false heterozygous SNVs/6 Gb), approximately 10 fold lower than
the previous published error rates using the same ligation-based sequencing chemistry18.
These accurate haplotypes allow detection of highly diverged human sequences
(Supplementary Materials and Supplementary Table 13) and many other applications.
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To demonstrate how LFR could be used in a diagnostic/prognostic environment we analysed
the coding SNP data of all libraries for two or more nonsense, splicesite, or PolyPhen234
predicted detrimental missense variations that co-occur in the same gene. Of these,
approximately 40 genes were found in each individual that contained a least one detrimental
variation in each allele (Table 2). Extending this analysis to variants which disrupt
transcription factor binding sites (TFBS) introduces an additional ~100 genes per individual
(additional analyses of the effects of TFBS disruption on allele specific expression can be
found in Supplementary Materials and Supplementary Table 12). Due to the high accuracy
of LFR it is unlikely that these variants are a result of sequencing errors and many could
have been introduced in the propagation of these cell lines. Further, some of these variants
are likely to have little to no effect on the function of these gene products35 and much more
work is required to understand how changes in TFBS sites effect transcription. A few of
these variants were found in unrelated individuals suggesting that they could be improperly
annotated or the result of a systematic mapping or reference error. The genome of NA19240
contained an additional ~10 genes predicted to have complete loss of function; this is most
likely due to biases introduced by using a European reference genome to annotate an
African genome. Nonetheless, these numbers are similar to those found in several recent
studies on phased individual genomes13,35,36 and suggest that most generally healthy
individuals probably have a small number of genes, not absolutely required for normal life,
which encode ineffective protein products. Additional studies are required to understand the
meaning of these types of changes. Importantly, we have demonstrated that LFR is able to
identify genes in which two detrimental variants are found in different alleles without the
need for costly verification35. This information is critical for effective clinical interpretation
of patient genomes.
Discussion
In this study we have demonstrated the efficiency of LFR to accurately phase up to 97% of
all detected heterozygous SNPs in a genome into long contiguous stretches of DNA (N50s
400-1500 kb in length). Even LFR libraries phased without candidate heterozygous SNPs
from standard libraries, and thus using only 10-20 human cells, are able to phase >90% of
the available SNP. In several instances, the LFR libraries used in this paper had less than
optimal starting input DNA (NA20431, Table1). Phasing rate improvements seen by
combining two replicate libraries or starting with more DNA (NA12892, Table 1) agree with
this conclusion. Additionally, underrepresentation of GC rich sequences resulted in less of
the genome being called (Supplementary Table 3). Improvements to the MDA process,
removal of amplification steps as future single molecule sequencing processes improve, or
modifications to how we perform base and variant calling in LFR libraries will help increase
the coverage in these regions (see Supplementary Materials and Supplementary Figure 12
for a demonstration of how LFR can make calls in low coverage regions). Moreover, as the
cost of whole genome sequencing continues to fall, higher coverage libraries, demonstrated
in this paper to dramatically improve call rates and phasing, will become more affordable.
A consensus haploid sequence is sufficient for many applications; however it lacks two very
important pieces of data for detecting disease causing variants in personal genomes: phased
heterozygous variants and identification of false positive and negative variant calls. By
providing sequence data from both the maternal and paternal chromosomes independently,
LFR is able to detect regions in the genome assembly where only one allele has been
covered. Likewise, false positive calls are avoided because LFR independently, in separate
aliquots, sequences both the maternal and paternal chromosomes 10-20 times. The result is a
statistically low probability that random sequencing or DNA amplification errors would
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trepeatedly occur in several aliquots at the same base position on one parental allele. Thus,
LFR allows, for the first time, both accurate and cost-effective sequencing of a genome from
a few human cells in spite of the required extensive DNA amplification. Further, by phasing
SNPs over hundreds of kilobases (or over entire chromosomes by integrating LFR with
routine genotyping of at least one parent), LFR is able to more accurately predict the effects
of compound regulatory variants and parental imprinting on allele specific gene expression
and function in various tissue types. Additionally, separation of mate-pair reads by
haplotype may also help in detecting expanded tri-nucleotide repeats in diseases like
Huntingtons, even though LFR does not provide direct length measure of these or similar
repeats. Taken together this provides a highly accurate report about the potential genomic
changes that could cause gain or loss of protein function. This kind of information, obtained
inexpensively for every patient, will be critical for clinical use of genomic data. Moreover,
successful and affordable diploid sequencing of a human genome starting from ten cells
opens the possibility for comprehensive and accurate genetic screening of micro biopsies
from diverse tissue sources such as circulating tumor cells or pre-implantation embryos
generated through in vitro fertilization.
Methods Summary
High molecular weight DNA was purified from cell lines GM12877, GM12878, GM12885,
GM12886, GM12891, GM12892 GM19240, and GM20431 (Coriell Institute for Medical
Research, Camden, NJ) using a RecoverEase DNA isolation kit (Agilent, La Jolla, CA)
following the manufacturer’s protocol. Individual cells of NA19240 were isolated under
200x magnification with a micromanipulator (Eppendorf, Hamburg, Germany) and
deposited into a 1.5 ml microtube with 10 ul of dH2O. LFR libraries were made as outlined
in the main text; a more detailed description can be found in the Supplementary Methods.
LFR libraries were sequenced, mapped, and assembled using the Complete Genomics’
sequencing pipeline. Phasing was performed using custom haplotyping algorithms as
described in Figure 2 and in further detail in the Supplementary Methods. Variations
adversely affecting protein function or expression were found using several methods.
Misssense variations were analyzed using Polyphen234. For this study both “possibly
damaging” and “probably damaging” were considered to be detrimental to protein function
as were all nonsense mutations. Variations determined to adversely affect mRNA splicing
were found with a custom algorithm based on consensus splice position models from Steve
Mount’s database37. JASPAR models38,39 were used to extract potential TFBSs from the
reference genome with mast40. Variations falling with these regions were compared to the
models to determine what affect they had upon transcription factor binding. Genes found to
have two or more detrimental mutations were only further analyzed if all mutations were
found within the same haplotype contig. More detailed descriptions of all methods used in
this paper can be found in the online Supplementary Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Overview of the Long Fragment Read (LFR) technology and controlled random
enzymatic (CoRE) fragmenting
(a) 100-130 pg of high molecular weight DNA is physically separated into 384 distinct
wells, (b) through several steps, all within the same well without intervening purifications,
the genomic DNA is amplified, fragmented, and ligated to unique barcode adapters, (c) all
384 wells are combined, purified, and introduced into Complete Genomics’ sequencing
platform10, (d) mate-paired reads are mapped to the genome using a custom alignment
program and barcode sequences are used to group tags into haplotype contigs, (e) the final
result is a diploid genome sequence.
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tFigure 2. LFR haplotyping algorithm
(a) Variation extraction: Variations are extracted from the aliquot tagged reads. The 10-base
Reed-Solomon codes enable tag recovery via error correction. (b) Heterozygous SNP-pair
connectivity evaluation: The matrix of shared aliquots is computed for each heterozygous
SNP-pair within a certain neighbourhood. Loop1 is over all the heterozygous SNPs on one
chromosome. Loop2 is over all the heterozygous SNPs on the chromosome which are in the
neighbourhood of the heterozygous SNPs in Loop1. This neighbourhood is constrained by
the expected number of heterozygous SNPs and the expected fragment lengths. (c) Graph
generation: An undirected graph is made, with nodes corresponding to the heterozygous
SNPs and the connections corresponding to the orientation and the strength of the best
hypothesis for the relationship between those SNPs. The orientation is binary and is shown
in the figure with a colour. Red and green depict a flipped and unflipped relationship
between heterozygous SNP pairs, respectively. The strength is defined by employing fuzzy
logic operations on the elements of the shared aliquot matrix. (d) Graph optimization: The
graph is optimized via a minimum spanning tree operation. (e) Contig generation: Each sub-
tree is reduced to a contig by keeping the first heterozygous SNP unchanged, and flipping or
not flipping the other heterozygous SNPs on the sub-tree, based on their paths to the first
heterozygous SNP. The designation of Parent 1 (P1) and Parent 2 (P2) to each contig is
arbitrary. The gaps in the chromosome-wide tree define the boundaries for different sub-
trees/contigs on that chromosome. (f) Optional mapping of LFR contigs to parental
chromosomes: Using parental information, a Mom or Dad label is placed on the P1 and P2
haplotypes of each contig.
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